Des Atouts Changement Date
Abbott USD 84.18B 182M 2025-09
AngioDynamics USD 285.41M 6.14M 2025-02
AtriCure USD 635.44M 26.59M 2025-09
Baxter International USD 21.07B 21M 2025-09
Becton, Dickinson and Co. USD 54.84B 484M 2025-12
Boston Scientific USD 42.71B 1.15B 2025-09
Chart Industries USD 9.79B 70.8M 2025-09
Cooper Companies USD 12.39B 18.1M 2025-09
Dexcom USD 7.5B 173M 2025-09
Edwards Lifesciences USD 13.27B 216.5M 2025-09
Globus Medical USD 5.1B 134.55M 2025-09
Inogen USD 307.01M 5.03M 2025-09
Insulet USD 3.03B 439.9M 2025-09
Masimo USD 1.82B 585.1M 2025-09
Medtronic USD 90.97B 708M 2025-06
Orthofix International USD 832.61M 4.55M 2025-09
Philips EUR 26.34B 40M 2025-09
ResMed USD 8.5B 195.02M 2025-12
Steris USD 10.59B 180.7M 2025-12
Stryker USD 47.84B 787M 2025-12
Tandem Diabetes Care USD 874.65M 1.08M 2025-09
Teleflex USD 7.87B 496.72M 2025-09
X T L Biopharmaceuticals USD 8.55M 730K 2024-12
Zimmer Biomet Holdings USD 23.09B 396.3M 2025-12


Inogen Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.